HF4201
Cannabis business and hemp business license provisions modified, and cannabinoid product and lower-potency hemp edible labeling requirements modified.
Legislative Session 94 (2025-2026)
Related bill: SF4429
AI Generated Summary
Purpose
- Clarify and expand how cannabis and hemp product licensing works in Minnesota.
- Tighten and standardize labeling for cannabis, hemp-derived products, and medical products.
- Permit new licensing combinations while imposing limits to prevent overlap with cannabis licenses.
- Establish clear requirements for how products are tested, labeled, and what information must be shown to consumers.
Main Provisions
Licensing options and limits
- People or businesses may hold any combination of lower-potency hemp edible licenses (manufacturer, wholesaler, retailer).
- Those hemp licenses can be held alongside an industrial hemp cultivation license, and can be held with other non-cannabis licenses (e.g., food, tobacco, nicotine products).
- A person with lower-potency hemp licenses may not hold a cannabis business license.
- Licenses must be issued to eligible applicants aged 21 or older, with annual renewal and no transfer of licenses.
Labeling for cannabis, hemp flower, and hemp products
- Cannabis flower, hemp plant parts, and hemp-derived consumer products sold to customers or patients must include:
- Name and license number of the license holder (e.g., cultivator, processor, or business class).
- Net weight and batch number.
- Cannabinoid profile.
- A universal symbol indicating product type (cannabis flower, cannabis product, lower-potency hemp edible, or hemp-derived product).
- Verification that the product was tested and complies with applicable standards.
- Usage directions and information on proper use.
- Warnings to keep out of reach of children and Poison Control information.
- Any other information required by the state office.
Medical cannabis labeling
- Medical cannabis products must also include patient-specific information on the label, such as patient name, date of birth, caregiver information (if applicable), and registry identification numbers.
Labeling for hemp-derived topicals
- All hemp-derived topical products must include:
- Manufacturer contact information and the testing laboratory’s details.
- Net weight, product type, and cannabinoid content per serving and total.
- List of ingredients.
- A disclaimer about claims (not diagnosing, treating, curing, or preventing disease) unless approved by the FDA.
- Other required information and testing verification.
- If a topical product contains THC, it must also show THC content, the THC universal symbol, a separate warning symbol, and Poison Control information, plus testing verification.
Special labeling for lower-potency hemp edibles
- Lower-potency hemp edibles must include:
- Information about the hemp cultivation and the producer of the hemp concentrate used in the product (or the license numbers if applicable).
- Net weight, batch number, serving size.
- Cannabinoid profile per serving and total THC.
- List of ingredients and the universal symbol for hemp products.
- A warning symbol, Poison Control information, testing verification, usage directions, and other required information.
- Retailers may provide the required information through a scannable barcode on the label if it is accurate and active.
Cannabinoid content and product approvals
- Products may contain cannabidiol (CBD) or cannabigerol (CBG), with the office allowed to approve additional non-intoxicating cannabinoids.
- Other cannabinoids may be allowed only if they are non-intoxicating and the total amount per package meets limits (overall limit of 1 milligram of other cannabinoids per package; total THC must not exceed 0.3% per package).
- Any cannabinoids beyond those approved must come from hemp concentrate naturally occurring in hemp plants or plant parts.
Additional labeling considerations
- The office can adopt alternative labeling for imported lower-potency hemp edibles if the information provided is substantially similar to the required disclosures.
Notable Changes to Existing Law
- Expanded license combinations and restrictions
- Allows combinations of hemp edible licenses with certain other licenses, but prevents holding a cannabis license if you hold hemp licenses.
- Strict license eligibility and renewal
- Establishes age 21+, annual renewal, no transfer of licenses, and prohibitions on certain conflicts of interest with state regulators.
- Comprehensive labeling overhaul
- Introduces uniform labeling content across cannabis, hemp, medical, and topical products, including testing verification, cannabinoid profiles, and consumer safety information.
- New disclosure mechanisms
- Enables the use of a scannable barcode to share required product information in lieu of printed text on the label for some hemp edibles.
- Strengthened medical labeling
- Requires patient and caregiver information on medical cannabis product labels.
- Potency and cannabinoid limits
- Sets a cap on total THC and restricts the presence of non-approved cannabinoids to very small amounts per package unless specifically approved.
How It Works in Practice
- Businesses must manage multiple license types (hemp edibles, potentially cannabis-related activities) and ensure all licenses are current and non-transferable.
- Product packaging must meet the detailed label content requirements, including testing verification, batch numbers, cannabinoid profiles, and clear safety information.
- Medical products will require patient registry details on their labels.
- Lower-potency hemp edibles will require extensive cultivation and manufacturing source information on the label, with an option to use a barcode for delivery of that information.
- Any cannabinoids beyond approved lists must be non-intoxicating and tightly limited, with total THC not exceeding 0.3%.
Relevant Terms - hemp - lower-potency hemp edible - cannabis - cannabis license - hemp edible license - cannabis microbusiness - cannabis mezzobusiness - industrial hemp grower - cannabis flower - hemp-derived product - universal symbol - warning symbol - Minnesota Poison Control Center - testing (section 342.61) - batch number - net weight - serving size - cannabinoid profile - cannabidiol (CBD) - cannabigerol (CBG) - non-intoxicating cannabinoids - hemp concentrate - scannable barcode - medical cannabis - medical cannabinoid product - independent accredited laboratory
Past committee meetings
You must be logged in to view 1 past legislative committee meetings.
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 12, 2026 | House | Action | Introduction and first reading, referred to | Commerce Finance and Policy | |
| Showing the 5 most recent stages. This bill has 1 stages in total. Log in to view all stages | |||||
Citations
You must be logged in to view citations.
Progress through the legislative process
Sponsors
You must be logged in to view sponsors.